Fibriant Steps Up Development of Fibrinogen Technology Platform with License from TNO
Exclusive License to Accelerate Development of New Breakthrough Products based on Specific Variants of Human Fibrinogen. Leiden, The Netherlands, September [...]
Exclusive License to Accelerate Development of New Breakthrough Products based on Specific Variants of Human Fibrinogen. Leiden, The Netherlands, September [...]
Fibriant sponsors the 2016 International Fibrinogen Workshop in South Africa Fibriant is one of the major sponsors of the XXIVth [...]
Fibriant and AMOLF enter into Research Collaboration Fibriant has entered into a collaborative research agreement with the AMOLF institute located [...]
Fibriant B.V. Today Fibriant BV announces that 5 new employees have joined the company to kick-start its operational activities. Fibriant [...]